Skip to main content

Table 4 Radio-chemotherapy related adverse events

From: Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC

 

Frequency

%

Esophagitis

14

58.3

 G1

7

29.2

 G2

5

20.8

 G3

2

8.3

Pneumonitis G1

1

4.2

Hematological toxicity

5

20.8

 G1

3

12.5

 G2

2

8.3